Patents by Inventor Thomas Severin

Thomas Severin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220184074
    Abstract: The present disclosure relates to methods for treating Chronic Spontaneous Urticaria using a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Also disclosed herein is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for treating Chronic Spontaneous Urticaria patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: May 20, 2020
    Publication date: June 16, 2022
    Inventors: Souvik BHATTACHARYA, Bruno BIETH, Maciej CABANSKI, Bruno CENNI, Stefan DE BUCK, Martin KAUL, Arvind KINHIKAR, Andrijana RADIVOJEVIC, Thomas SEVERIN, Julian STORIM, Alessandra VITALITI GARAMI
  • Publication number: 20210115155
    Abstract: The present disclosure relates to methods for treating Chronic Spontaneous Urticaria using IgE antagonists, e.g., ligelizumab. Also disclosed herein are IgE antagonists, e.g., IgE antibodies, such as ligelizumab, for treating Chronic Spontaneous Urticaria patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: March 25, 2019
    Publication date: April 22, 2021
    Inventors: Reinhold Martin JANOCHA, Stephan KOEHNE-VOSS, Philip John LOWE, Thomas SEVERIN
  • Publication number: 20190022189
    Abstract: Growth differentiation factor 15 (GDF-15) is a stress-responsive cytokine known to be associated with adverse events in heart failure patients. The use of serelaxin has been shown to affect GDF-15 levels at baseline and decreases in GDF-15 levels over time. Measuring GDF-15 levels allows a healthcare provider to accurately predict pulmonary load in patients with pulmonary congestion.
    Type: Application
    Filed: September 21, 2018
    Publication date: January 24, 2019
    Inventors: Margaret Forney Prescott, Yiming Zhang, Marion Dahlke, Thomas Severin
  • Publication number: 20170100460
    Abstract: Growth differentiation factor 15 (GDF-15) is a stress-responsive cytokine known to be associated with adverse events in heart failure patients. The use of serelaxin has been shown to affect GDF-15 levels at baseline and decreases in GDF-15 levels over time. Measuring GDF-15 levels allows a healthcare provider to accurately predict pulmonary load in patients with pulmonary congestion.
    Type: Application
    Filed: June 10, 2015
    Publication date: April 13, 2017
    Applicant: NOVARTIS AG
    Inventors: Margaret Forney Prescott, Yiming Zhang, Marion Dahlke, Thomas Severin
  • Patent number: 9560273
    Abstract: The invention is related to a wearable information system having at least one camera, the information system operable to have a low-power mode and a high power mode. The information system is configured such that the high-power mode is activated by a detection of at least one object in at least one field of view of the at least one camera.
    Type: Grant
    Filed: February 21, 2014
    Date of Patent: January 31, 2017
    Assignee: Apple Inc.
    Inventors: Peter Meier, Thomas Severin
  • Publication number: 20170013195
    Abstract: The invention is related to a wearable information system having at least one camera, the information system operable to have a low-power mode and a high power mode. The information system is configured such that the high-power mode is activated by a detection of at least one object in at least one field of view of the at least one camera.
    Type: Application
    Filed: September 22, 2016
    Publication date: January 12, 2017
    Inventors: Peter Meier, Thomas Severin
  • Publication number: 20150244935
    Abstract: The invention is related to a wearable information system having at least one camera, the information system operable to have a low-power mode and a high power mode. The information system is configured such that the high-power mode is activated by a detection of at least one object in at least one field of view of the at least one camera.
    Type: Application
    Filed: February 21, 2014
    Publication date: August 27, 2015
    Applicant: Metaio GmbH
    Inventors: Peter Meier, Thomas Severin
  • Patent number: 8204588
    Abstract: A cardiac pacemaker, defibrillator, or other programmable medical device (25) includes a source unit (15) and a collection unit (20). The source unit (15) has a check data unit (40) generating at least one check datum for control data for the medical device (25), and a transmitting unit (45) transmitting the control data and the check datum to the collection unit (20). The collection unit (20) has a storage unit (65) storing the control data, a check unit (70) checking the integrity of the control data using the check datum, and a transmitting unit (75) transmitting the control data to a programmable control unit (80) of the medical device (25) only if the integrity of the control data is established by the check unit (70). The control unit (80) of the medical device (25) controls the functions of the medical device (20) on the basis of the transmitted control data.
    Type: Grant
    Filed: July 7, 2008
    Date of Patent: June 19, 2012
    Assignee: Biotronik CRM Patent AG
    Inventors: Thomas Severin, Joern Bungartz
  • Patent number: 7983753
    Abstract: The invention relates to a remotely-programmable personal device, in particular a programmable implantable medical device, such as a cardiac pacemaker, a defibrillator, a cardioverter, or the like. In addition, the invention relates to a configuration for the remote programming of such a personal medical device and a method for remotely programming a programmable personal device.
    Type: Grant
    Filed: August 26, 2008
    Date of Patent: July 19, 2011
    Assignee: Biotronik CRM Patent AG
    Inventor: Thomas Severin
  • Publication number: 20090069860
    Abstract: The invention relates to a remotely-programmable personal device, in particular a programmable implantable medical device, such as a cardiac pacemaker, a defibrillator, a cardioverter, or the like. In addition, the invention relates to a configuration for the remote programming of such a personal medical device and a method for remotely programming a programmable personal device.
    Type: Application
    Filed: August 26, 2008
    Publication date: March 12, 2009
    Inventor: Thomas SEVERIN
  • Publication number: 20090054937
    Abstract: A cardiac pacemaker, defibrillator, or other programmable medical device (25) includes a source unit (15) and a collection unit (20). The source unit (15) has a check data unit (40) generating at least one check datum for control data for the medical device (25), and a transmitting unit (45) transmitting the control data and the check datum to the collection unit (20). The collection unit (20) has a storage unit (65) storing the control data, a check unit (70) checking the integrity of the control data using the check datum, and a transmitting unit (75) transmitting the control data to a programmable control unit (80) of the medical device (25) only if the integrity of the control data is established by the check unit (70). The control unit (80) of the medical device (25) controls the functions of the medical device (20) on the basis of the transmitted control data.
    Type: Application
    Filed: July 7, 2008
    Publication date: February 26, 2009
    Inventors: Thomas Severin, Joern Bungartz